Indian pharmaceutical stocks may experience a potential resurgence in 2024, driven by increasing exports, strategic shifts in global markets, and a rising demand for affordable healthcare. Let’s explore the key drivers behind this resurgence and highlight the companies to watch as the industry charts a promising path forward.